Balance Sheet - Lexeo Therapeutics, Inc. (LXEO)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total cash and short-term investments | 181.77 | 121.52 | 121.47 | 77.34 | 135.86 | 29.37 |
| Other current assets | 6.63 | 4.60 | 2.83 | 2.71 | 0.82 | 0.03 |
| Total current assets | 188.39 | 126.12 | 124.29 | 80.05 | 136.68 | 29.41 |
| Total non-current assets | 80.30 | 20.82 | 15.51 | 21.26 | 0.18 | 0.00 |
| Total assets | 268.69 | 146.94 | 139.81 | 97.08 | 136.86 | 29.41 |
| Total current liabilities | 16.81 | 22.85 | 17.24 | 14.35 | 7.45 | 0.70 |
| Total non-current liabilities | 5.21 | 7.25 | 9.03 | 195.68 | 185.01 | 34.25 |
| Total liabilities | 22.02 | 30.10 | 26.27 | 210.03 | 192.46 | 34.95 |
| Total stockholders' equity | 246.67 | 116.84 | 113.54 | -112.95 | -55.60 | -5.54 |
| Common shares outstanding | 54 | 32 | 27 | 25 | 25 | 25 |
Show Quarterly Balance Sheet
Balance Sheet - Lexeo Therapeutics, Inc. (LXEO)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 193.04 | 181.77 | 122.76 | 132.89 | 99.83 | 121.52 | 157.02 | 174.98 | 195.06 | 121.47 | 35.45 | 45.54 | 58.85 | 77.34 | 0.00 | 0.00 | 0.00 |
| Other current assets | 129.09 | 6.63 | 86.80 | 7.17 | 5.44 | 4.60 | 2.44 | 2.17 | 3.03 | 2.83 | 3.43 | 3.17 | 2.37 | 2.71 | |||
| Total current assets | 200.86 | 188.39 | 127.79 | 140.06 | 105.27 | 126.12 | 159.46 | 177.15 | 198.09 | 124.29 | 38.87 | 48.71 | 61.22 | 80.05 | |||
| Total non-current assets | 49.49 | 80.30 | 16.05 | 36.01 | 20.42 | 20.82 | 14.41 | 14.86 | 15.12 | 15.51 | 15.85 | 16.23 | 16.60 | 17.03 | |||
| Total assets | 250.36 | 268.69 | 143.84 | 176.07 | 125.69 | 146.94 | 173.87 | 192.01 | 213.21 | 139.81 | 54.72 | 64.94 | 77.82 | 97.08 | |||
| Total current liabilities | 14.19 | 16.81 | 17.27 | 31.59 | 30.82 | 22.85 | 26.82 | 18.88 | 21.63 | 17.24 | 23.04 | 13.66 | 13.69 | 14.35 | |||
| Total non-current liabilities | 4.67 | 5.21 | 5.74 | 6.26 | 6.75 | 7.25 | 7.72 | 8.18 | 8.63 | 9.03 | 194.50 | 194.90 | 10.28 | 195.68 | |||
| Total liabilities | 18.86 | 22.02 | 23.01 | 37.85 | 37.58 | 30.10 | 34.54 | 27.06 | 30.26 | 26.27 | 217.53 | 208.56 | 23.97 | 210.03 | |||
| Total stockholders' equity | 231.50 | 246.67 | 120.83 | 138.22 | 88.12 | 116.84 | 139.33 | 164.95 | 182.95 | 113.54 | -162.81 | -143.62 | 53.85 | -112.95 | |||
| Common shares outstanding | 81 | 76 | 61 | 44 | 33 | 33 | 33 | 33 | 28 | 27 | 25 | 25 | 25 | 25 | 25 | 25 | 27 |